This study aims to comprehensively characterize the clinical significance, molecular mechanisms, and therapeutic potential of SEC23A in GC.<h4>Methods</h4>We systematically analyzed SEC23A expression and its prognostic value in GC cohorts from The Cancer Genome Atlas and Gene Expression Profiling Interactive Analysis. The gene discussed is SEC23A; the disease is gastric cancer.